Back to search results

A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors

Abroad (travel likely)RecruitingPHASE1

Conditions

Advanced Breast Cancer · Metastatic Breast Cancer (HR+/ HER2-) · Colorectal Cancer · Metastatic Colorectal Adenocarcinoma · Triple Negative Breast Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • City of Hope (City of Hope National Medical Center, City of Hope Medical Center), Duarte, California, United States

  • START Midwest, LLC, Grand Rapids, Michigan, United States

  • Memorial Sloan Kettering Cancer Center - Investigational Drug Service Pharmacy, Long Island City, New York, United States

  • Memorial Sloan Kettering Cancer Center - David H. Koch Center for Cancer Care (74th Street)., New York, New York, United States

  • Memorial Sloan Kettering Cancer Center 53rd street., New York, New York, United States

  • Memorial Sloan Kettering Cancer Center - Main Campus, New York, New York, United States

  • The University of Texas MD Anderson Cancer Center - Conroe, Conroe, Texas, United States

  • The University of Texas - M.D. Anderson Cancer Center, Houston, Texas, United States

  • The University of Texas, MD Anderson Cancer Center - West Houston, Houston, Texas, United States

  • The University of Texas, MD Anderson Cancer Center - League City, League City, Texas, United States

  • START San Antonio, San Antonio, Texas, United States

  • The University of Texas, MD Anderson Cancer Center - Sugar Land, Sugar Land, Texas, United States

  • START Mountain Region, West Valley City, Utah, United States

Study leads

  • Pfizer CT.gov Call Center

    Study Director

    Pfizer

View source on ClinicalTrials.gov(opens in a new tab)